[PDF][PDF] treatment controversy
CJH Van de Velde, K Peeters - J Clin Oncol, 2003 - scholarlypublications …
PURPOSE: To evaluate the survival benefit of adjuvant chemotherapy after curative
resection in serosa-negative gastric cancer patients (excluding patients who were T1N0), we …
resection in serosa-negative gastric cancer patients (excluding patients who were T1N0), we …
[引用][C] The Gastric Cancer Treatment Controversy
CJH van de Velde, KCMJ Peeters - Journal of Clinical Oncology, 2003 - cir.nii.ac.jp
The Gastric Cancer Treatment Controversy | CiNii Research CiNii 国立情報学研究所 学術情報
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …
[引用][C] The Gastric Cancer Treatment Controversy
CJH van de Velde, KCMJ Peeters - Journal of Clinical Oncology, 2003 - ascopubs.org
GASTRIC CANCER is still a major problem. It is the most frequent cause of cancer-related
deaths worldwide, although its incidence has steadily declined during the last decades in …
deaths worldwide, although its incidence has steadily declined during the last decades in …
[引用][C] The gastric cancer treatment controversy.
CJ van de Velde, KC Peeters - … Journal of the American Society of …, 2003 - europepmc.org
The gastric cancer treatment controversy. - Abstract - Europe PMC Sign in | Create an account
https://orcid.org Europe PMC Menu About Tools Developers Help Contact us Helpdesk …
https://orcid.org Europe PMC Menu About Tools Developers Help Contact us Helpdesk …
[引用][C] The gastric cancer treatment controversy
CJH van de Velde… - Journal of clinical …, 2003 - pubmed.ncbi.nlm.nih.gov